CorMedix Inc share price logo

CorMedix Inc

NASDAQ: CRMD

Small Cap

$7.83

+0.41

(+5.46%)

as on

CorMedix Inc Stock Performance

as on April 28, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $7.48
    $7.91
    downward going graph

    4.47%

    Downside

    1.02%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $6.13
    $17.43
    downward going graph

    21.78%

    Downside

    122.61%

    Upside

    downward going graph

CorMedix Inc share price movements today

Previous Close
$7.42
Open
$7.53
Volume
2.0M
Day's Low - High
$7.48 - $7.91
52 Week Low - High
$6.13 - $17.43

CorMedix Inc Historical Returns

1 Month Return
+ 10.58 %
3 Month Return
-4.26 %
1 Year Return
-18.46 %
3 Year Return
+ 60.26 %
5 Year Return
-11.56 %

CorMedix Inc Stock Fundamentals & Key Indicators

Check CorMedix Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$586.6M

EPS (TTM)

0.79

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.28%

PE Ratio (TTM)

3.64

Industry PE ratio

-3.4861123595505616

PEG Ratio

0

EBITDA

174.9M

Revenue (TTM)

311.7M

Profit Margin

52.31%

Return On Equity TTM

66.56%

CorMedix Inc Stock Valuation

Track how CorMedix Inc P/E has moved over time to understand its valuation trends.

CorMedix Inc in the last 5 years

  • Overview

  • Trends

Lowest (-30.27x)

December 31, 2024

Industry (-3.49x)

April 27, 2026

Today (3.64x)

April 27, 2026

Highest (47.20x)

March 31, 2025

LowHigh

Today’s Price to Earnings Ratio: 3.64x

CorMedix Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of CorMedix Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
CorMedix Inc image
CorMedix Inc
BUY$586.6M-11.56%3.6452.31%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$40.8B116.23%131.78.45%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$109.5B99.64%28.132.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$33.4BNA121.785.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$79.5B52.82%18.1131.41%

Stock Returns calculator for CorMedix Inc Stock including INR - Dollar returns

The CorMedix Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

CorMedix Inc investment value today

Current value as on today

₹95,165

Returns

-₹4,835

(-4.84%)

Returns from CorMedix Inc Stock

-₹13,956 (-13.96%)

Dollar Impact

₹9,121 (+9.12%)

Analyst Recommendation on CorMedix Inc Stock

Based on 10 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for CorMedix Inc. Average target price of $14.57

CorMedix Inc Share Price Target

Get share price movements and forecasts by analysts on CorMedix Inc.

What analysts predicted

46.26%UPSIDE

Target Price

$14.57

Current Price

$7.83

Analyzed by

10 Analysts

Target

$14.57

CorMedix Inc target price $14.57, a slight upside of 46.26% compared to current price of $7.83. According to 10 analysts rating.

CorMedix Inc Stock’s Investor Sentiment and Interest

Search interest for CorMedix Inc Stock has decreased by -35% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-35% versus previous 30 day period

CorMedix Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
0
-
0
11
31
39
39
104
128
Gross Profit
0
0
0
0
10
30
37
37
93
107
Operating Income
-10
-15
-16
-15
-3
12
20
19
51
59
EBITDA
-9
-14
-15
-14
-2
13
20
20
57
66
Interest Expense
0
0
0
0
0
0
0
0
0
1
Depreciation
0
0
0
0
0
0
0
0
3
10
Income Before Tax
-9
-14
-15
-14
-2
13
20
20
52
56
Income Tax Expense
0
0
-1
0
0
-
-
0
-55
42
Net Income
-9
-14
-14
-14
-2
13
20
19
108
14
Net Profit Margin
0.00%
-4851.54%
0.00%
-1755.51%
-24.24%
43.14%
52.82%
49.90%
104.11%
10.90%

CorMedix Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
0
0
0
0
0
0
-
43
311
Gross Profit
0
0
0
0
0
0
0
0
40
275
Operating Income
-24
-32
-26
-21
-27
-29
-30
-48
-22
150
EBITDA
-24
-32
-26
-20
-27
-29
-30
-46
-18
165
Interest Expense
0
0
0
0
0
0
0
0
0
2
Depreciation
-
0
0
0
0
0
0
0
0
14
Income Before Tax
-24
-33
-26
-11
-27
-29
-30
-46
-19
150
Income Tax Expense
0
0
0
5
-5
-1
0
0
-1
-13
Net Income
-24
-33
-26
-16
-22
-28
-29
-46
-17
163
Net Profit Margin
-10996.46%
-10023.45%
-6242.40%
-5801.29%
-9207.70%
-14774.70%
-45409.90%
0.00%
-41.24%
52.31%

CorMedix Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-14
-14
-14
-2
13
20
19
108
14
Operating Cash Flow
-10
-17
-14
-13
-5
19
29
30
94
Investing Cash Flow
0
8
6
6
0
0
-20
-291
3
Financing Cash Flow
0
0
1
14
11
6
83
150
-1
Change in Cash
-9
-8
-6
6
5
25
93
-109
96

CorMedix Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-33
-26
-16
-22
-28
-29
-46
-17
163
Operating Cash Flow
-28
-23
-15
-21
-21
-24
-38
-50
175
Investing Cash Flow
10
1
-12
7
-9
-3
-17
21
-308
Financing Cash Flow
20
29
25
40
41
17
55
26
238
Change in Cash
2
7
-1
25
11
-10
0
-3
105

Global Institutional Holdings in CorMedix Inc

Funds
Holdings
Morgan Stanley - Brokerage Accounts
1.07%
The Goldman Sachs Group Inc
1.05%
Deep Track Capital, LP
0.63%
Citadel Advisors Llc
0.4%
Nuveen, LLC
0.88%
See all

CorMedix Inc News & Key Events

    Insights on CorMedix Inc

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Best in 3 Years

      img

      In the last 3 years, CRMD has outperformed top 5 stocks with highest market-cap in its industry

    • imgPOSITIVE IMPACT

      Revenue Rich

      img

      Revenue is up for the last 10 quarters, 6.81K → 128.61M (in $), with an average increase of 54.3% per quarter

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 24.7% return, outperforming this stock by 43.2%

    • imgNEGATIVE IMPACT

      Price Dip

      img

      In the last 6 months, CRMD stock has moved down by -32.9%

    • imgNEGATIVE IMPACT

      Profit Down

      img

      Netprofit is down for the last 2 quarters, 108.56M → 14.02M (in $), with an average decrease of 87.1% per quarter

    About CorMedix Inc

    CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. CorMedix Inc. was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. The company was incorporated in 2006 and is based in Parsippany, New Jersey.
    OrganisationCorMedix Inc
    Headquarters389 Interpace Pkwy, Parsippany, NJ, United States, 07054
    IndustryBiotechnology
    CEOMr. Joseph Todisco MBA
    E-voting on sharesClick here to vote

    Key Management of CorMedix Inc

    Name

    Title

    Ms. Elizabeth Masson-Hurlburt B.A.

    Executive VP, Chief Operating Officer & Chief Integration Officer

    Dr. Tushar Mukherjee

    Senior VP & Head of Technical Operations

    Dr. Peter Sullivan BCOP, Pharm.D.

    Senior Vice President of Market Access

    Ms. Beth Steinbrenner

    SVP & Chief Human Resource Officer

    Donna Ucci

    Senior VP & Head of Global Quality

    Mr. Michael Seckler

    EVP & Chief Commercial Officer

    Mr. Joseph Todisco MBA

    CEO & Chairman of the Board of Directors

    Dr. Matthew T. David M.D.

    EVP & Chief Business Officer

    Ms. Susan Blum

    EVP & Chief Financial Officer

    Ms. Kaufman Beth Zelnick Esq.

    EVP, Chief Legal and Compliance Officer & Corporate Secretary

    FAQs

    What is CorMedix Inc share price today?

    CorMedix Inc share price today is $7.83 as on at the close of the market. CorMedix Inc share today touched a day high of $7.91 and a low of $7.48.

    What is the 52 week high and 52 week low for CorMedix Inc share?

    CorMedix Inc share touched a 52 week high of $17.43 on and a 52 week low of $6.13 on . CorMedix Inc stock price today i.e. is closed at $7.83,which is 55.08% down from its 52 week high and 27.84% up from its 52 week low.

    What is CorMedix Inc's market capitalisation today?

    CorMedix Inc market capitalisation is $0.00T as on .

    How to invest in CorMedix Inc Stock (CRMD) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for CorMedix Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in CorMedix Inc Shares that will get you 0.1916 shares as per CorMedix Inc share price of $7.83 per share as on April 28, 2026 at 1:29 am IST.

    What is the minimum amount required to buy CorMedix Inc Stock (CRMD) from India?

    Indian investors can start investing in CorMedix Inc (CRMD) shares with as little as ₹94.19 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹941.90 in CorMedix Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on CorMedix Inc share’s latest price of $7.83 as on April 28, 2026 at 1:29 am IST, you will get 1.2771 shares of CorMedix Inc. Learn more about fractional shares .

    What are the returns that CorMedix Inc has given to Indian investors in the last 5 years?

    CorMedix Inc stock has given -11.56% share price returns and 26.36% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?